ABSTRACT
We generated two human induced pluripotency stem cell (hiPSC) lines, RCMGi011-A and 11-B, from skin fibroblast from patient with Mucopolysaccharidosis IV B type and autosomal recessive non-syndromic hearing loss 12 using non-integrating, viral CytoTune™-iPS 2.0 Sendai Reprogramming Kit. We verified variant c.808 T > G and insertion in GLB1 gene, as well as two mutations, c.6992 T > C and c.805C > T, in CDH23 gene which lead to autosomal recessive hearing loss type 12. We have demonstrated normal karyotype of hiPSCs and capacity for cell differentiation into three germ layers.
Subject(s)
Hearing Loss , Induced Pluripotent Stem Cells , Mucopolysaccharidosis IV , Humans , Cell Differentiation , Fibroblasts , Hearing Loss/geneticsABSTRACT
Microarray analysis of cultured endothelial cells was performed 24 h after simulated microgravity. A significant change in the expression of 177 genes that can be classified into several functional clusters was detected. Among the genes with overexpression, clusters of cell response to external stimuli and regulation of cell motility and proliferation can be reliably distinguished. Among down-regulated genes, clusters of transcription factors with the "zinc fingers" domain and factors involved in the regulation of morphogenesis and angiogenesis were distinguished. The overlapping of signaling pathways involved in mechanotransduction and inflammatory changes is discussed.
Subject(s)
Human Umbilical Vein Endothelial Cells/metabolism , Transcriptome , Weightlessness , Cell Movement/genetics , Cell Proliferation/genetics , Human Umbilical Vein Endothelial Cells/physiology , Humans , Transcription Factors/genetics , Transcription Factors/metabolismABSTRACT
The review summarizes the results of studying the space and simulated microgravity effects on cell-to-cell interactions in three models: 1) interaction of a human lymphocytes culture with a subinoculated suspension culture of tumor myeloblasts K-562; 2) formation of embryoid bodies and differentiation of mice embryonic stem cells (ESCs); 3) gene differentiation and expression in multipotent mesenchymal cells (MCSs) obtained from the human marrow. It was shown that microgravity modifies the cell-to-cell interactions without cell contact inhibition; however, micro-g causes reversible changes in expression of genes responsible for regulation of the cytoskeleton, focal adhesion proteins, and some cytokines. Prolonged exposure of progenitor cells in simulated microgravity inhibits the differentiation processes of and reprofiles significantly expression of the genes that control various cell activities, including cell-to-cell interactions.
Subject(s)
Models, Biological , Space Flight , Weightlessness Simulation , Aerospace Medicine , Animals , Cells, Cultured , Embryonic Stem Cells/metabolism , Gene Expression Regulation/physiology , Humans , K562 Cells , Lymphocytes/metabolism , Mesenchymal Stem Cells/metabolism , Mice , Time FactorsABSTRACT
Prophylaxis of hemolytic disease of newborns is based on the ability of polyclonal anti-D antibodies for suppressing maternal immune response against D-positive fetal red blood cells. The immunosuppressive effect of anti-D antibody is mediated by interaction between its Fc-fragment and low-affinity IgG Fc-receptor (FcγR) on the immune cell. No clinically effective monoclonal anti-D antibody (mAb) that can replace polyclonal anti-D immunoglobulin has been developed yet. The goals of this study were comparison of structural and functional properties of human anti-D polyclonal and monoclonal Abs and assessment of the possibility to manipulate the effector properties of the mAb. N-Glycosylation and particularly the content of nonfucosylated glycans are crucial for affinity of mAb to FcγRIIIA, which plays the key role in the clearance of sensitized cells. We studied and compared glycoprofiles and FcγRIIIA-mediated hemolytic ability of human polyclonal antibodies and anti-D mAbs produced by human B-cell lines, human-rodent heterohybridomas, and a human non-lymphoid cell line PER.C6. Replacement of producing cell line and use of glycosylation modulators can convert an inert mAb into an active one. Nevertheless, rodent cell lines, as well as human non-lymphoid cells, distort natural glycosylation of human IgG and could lead to the loss of immunosuppressive properties. All of the anti-D mAbs secreted by human B-cell lines have a glycoprofile close to human serum IgG. Hence, the constant ratio of IgG glycoforms in human serum is predetermined by glycosylation at the level of the individual antibody-producing cell. The anti-D fraction of polyclonal anti-D immunoglobulin compared to the total human IgG contains more nonfucosylated glycans. Thus, only human transformed B-cells are an appropriate source for efficient anti-D mAbs that can imitate the action of polyclonal anti-D IgG.
Subject(s)
Antibodies, Monoclonal/immunology , Antibody-Dependent Cell Cytotoxicity/immunology , Immunosuppressive Agents/immunology , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/isolation & purification , Cell Line , Glycosylation , Humans , Immunosuppressive Agents/chemistry , Immunosuppressive Agents/isolation & purification , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Recombinant Proteins/isolation & purificationABSTRACT
Creation of effective monoclonal anti-D immunoglobulin for prevention of hemolytic disease of the newborn remains an unsolved problem because there is still no producer cell strain providing stable production and adequate glycosylation of antibodies. Recombinant anti-D have been obtained on the basis of human PER.C6(®) cells and characterized. Anti-D antibodies expressed in PER.C6(®) exhibited lower hemolytic activity in antibody-dependent cytotoxicity (ADCC) reaction mediated by low-affinity Fcγ receptors in comparison with identical antibodies of lymphoblastoid origin. Monoclonal antibodies produced by PER.C6(®) are completely fucosylated and desialylated, i.e. are characterized by abnormal glycosylation. Addition of kifunensine (α-mannosidase I inhibitor) to the medium led to production of antibodies with high hemolytic activity. Reduced activity of monoclonal antibodies in PER.C6(®) cells and the effect of kifunensine (causing synthesis of defucosylated glycans) suggest that the absence of fucose is the key factor responsible for Fc affinity for low-affinity receptors.
Subject(s)
Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/metabolism , Immunoglobulin G/immunology , Rho(D) Immune Globulin/immunology , Glycosylation , Humans , Receptors, Fc/metabolismABSTRACT
Autooscillation of the surface tension is a phenomenon related to Marangoni instability periodically arising and fading by dissolution of a surfactant droplet under a water-air interface. A detailed experimental investigation was performed to clear up the influence of the system geometry on development and characteristics of autooscillations. It was found that the aspect ratio is an additional dimensionless parameter that determines the system behavior equally to the Marangoni number. The influence of the cell diameter, capillary immersion depth, and droplet radius on the autooscillation period and amplitude was studied as well.
ABSTRACT
Most of the data accumulated throughout the years on investigation of catalytic antibodies indicate that their production increases on the background of autoimmune abnormalities. The different approaches to induction of catalytic response toward recombinant gp120 HIV-1 surface protein in mice with various autoimmune pathologies are described. The peptidylphosphonate conjugate containing structural part of gp120 molecule is used for reactive immunization of NZB/NZW F1, MRL, and SJL mice. The specific modification of heavy and light chains of mouse autoantibodies with Val-Ala-Glu-Glu-Glu-Val-PO(OPh)2 reactive peptide was demonstrated. Increased proteolytic activity of polyclonal antibodies in SJL mice encouraged us to investigate the production of antigen-specific catalytic antibodies on the background of induced experimental autoimmune encephalomyelitis (EAE). The immunization of autoimmune-prone mice with the engineered fusions containing the fragments of gp120 and encephalitogenic epitope of myelin basic protein (MBP(89-104)) was made. The proteolytic activity of polyclonal antibodies isolated from the sera of autoimmune mice immunized by the described antigen was shown. Specific immune response of SJL mice to these antigens was characterized. Polyclonal antibodies purified from sera of the immunized animals revealed proteolytic activity. The antiidiotypic approach to raise the specific proteolytic antibody as an "internal image" of protease is described. The "second order" monoclonal antibodies toward subtilisin Carlsberg revealed pronounced proteolytic activity.